Exploratory analysis of trifluridine/tipiracil in late-stage metastatic colorectal cancer (mCRC): Prognostic factors.

Meinolf Karthaus,B Hoell,Gregor Zaun,M. Guyot,Martin Schuler,Stefan Kasper

Exploratory analysis of trifluridine/tipiracil in late-stage metastatic colorectal cancer (mCRC): Prognostic factors.

2020

Meinolf Karthaus
B Hoell
Gregor Zaun
M. Guyot
Martin Schuler
Stefan Kasper

24Background: Trifluridine/Tipiracil (FTD/TPI) is effective in pts with refractory mCRC. Enrollment into in the RECOURSE trial was allowed only for pts with ECOG < 1 pts, while real world pts may h...

Keywords:

Trifluridine
Internal medicine
Medicine
Oncology
Colorectal cancer
Tipiracil
Pathology
Refractory
exploratory analysis
late stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations